Quick jump to page content
Main Navigation
Main Content
Sidebar
Share
Publisher Home
Register
Login
Toggle navigation
Home
About
About the Journal
Editorial Team
Retraction Charges
Editorial Responsibilities
Publication Ethics and Malpractice Statement
Ethics
Online First
Contact
Current
Archives
Conference
Special Issue
Improving Health and Longevity: The challenge of Lifestyle Medicine
Recent Trends and Emerging Approaches in the Treatment of Type 2 Diabetes
Submissions
Login
Search
Home
Archives
Vol. 16 No. 2 (2009)
Published:
2018-12-08
Articles
COST- EFFECTIVENESS OF INTENSIVE LIPID LOWERING THERAPY WITH 80 MG OF ATORVASTATIN, VERSUS 10 MG OF ATORVASTATIN, FOR SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN CANADA
Monika Wagner, Mireille Goetghebeur, Elizabeth Merikle, Ankur Pandya, Paula Chu, Douglas CA Taylor
Abstract
250 | PDF Downloads
147
PDF
ACCESS AND INTENSITY OF USE OF PRESCRIPTION ANALGESICS AMONG OLDER MANITOBANS
Cheryl A Sadowski, Anita G Carrie, Ruby E Grymonpre, Colleen J Metge, Philip St.John
Abstract
184 | PDF Downloads
89
PDF
Innovations in Pharmacology - CSPT 2009 Conference Abstracts
Saskatoon, Saskatchewan
Abstract
133 | PDF Downloads
108
PDF
VALIDITY OF PERINATAL PHARMACOEPIDEMIOLOGIC STUDIES USING DATA FROM THE RAMQ ADMINISTRATIVE DATABASE
Anick Bérard, Anaïs Lacasse
Abstract
297 | PDF Downloads
177
PDF
CLINICAL EVALUATION OF DE MARCO FORMULA AS AN ADJUNCTIVE THERAPY FOR INFECTED ISCHEMIC DIABETIC FOOT: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
Héctor Álvarez Duarte, José I Fernández Montequín, Martha M Fors López, José Hernández Carretero, Miriam Mahia Vilas, Milagros García Mesa
Abstract
151 | PDF Downloads
77
PDF
THE UNINTENDED (AND COSTLY) EFFECTS DUE TO THE INTRODUCTION OF AN UNRESTRICTED REIMBURSEMENT POLICY FOR ATYPICAL ANTIPSYCHOTIC MEDICATIONS IN A CANADIAN PUBLIC PRESCRIPTION DRUG PROGRAM: 1996/97 TO 2005/06
Daria J O’Reilly, Ron A Goeree, Jean-Eric Tarride, Colleen Janes, Patrick S Parfrey
Abstract
145 | PDF Downloads
77
PDF
VIDENCE AND VALUES: REQUIREMENTS FOR PUBLIC REIMBURSEMENT OF DRUGS FOR RARE DISEASES - A CASE STUDY IN ONCOLOGY
Michael Drummond, Bill Evans, Jacques LeLorier, Pierre Karakiewicz, Douglas Martin, Peter Tugwell, Stuart MacLeod
Abstract
523 | PDF Downloads
209
PDF
Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply
Andreas Laupacis
Abstract
152 | PDF Downloads
83
PDF
A Critical Review of: “Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications”
Ran D. Goldman
Abstract
87 | PDF Downloads
55
PDF
ETHYLGLUCURONIDE AND ETHYLSULFATE IN MECONIUM TO ASSESS GESTATIONAL ETHANOL EXPOSURE: PRELIMINARY RESULTS IN TWO MEDITERRANEAN COHORTS
Simona Pichini, Luca Morini, Emilia Marchei, Ilaria Palmi, Maria Concetta Rotolo, Federica Vagnarelli, Oscar Garcia-Algar, Oriol Val, Piergiorgio Zuccaro
Abstract
228 | PDF Downloads
134
PDF
WERE OUR FOREBEARS AWARE OF PRENATAL ALCOHOL EXPOSURE AND ITS EFFECTS? A REVIEW OF THE HISTORY OF FETAL ALCOHOL SPECTRUM DISORDER
James L Sanders
Abstract
499 | PDF Downloads
395
PDF
THE RELATION BETWEEN THEORY OF MIND AND EXECUTIVE FUNCTIONS IN CHILDREN WITH FETAL ALCOHOL SPECTRUM DISORDERS
Carmen Rasmussen, Katy Wyper, Victoria Talwar
Abstract
1300 | PDF Downloads
525
PDF
×
Modal Header